Prognostic markers predict the course of a disease; for example, cancer antigen19-9 (CA19-9) in pancreatic cancer and carcinoembryonic antigen in colon cancer [32, 33]. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.